14.12.2020 • NewsElementis

Elementis Rejects Minerals’ Third Offer

Undeterred by the rejection of its two previous offers, Minerals Technologies submitted a revised and third proposal on Dec. 4 to take over UK specialty chemicals company Elementis.

The US specialty minerals firm raised its cash offer to 130 pence per share, up from its prior offer of 117 pence per share. The first offer was at 107 pence per share.

However, once again, the Elementis board has unanimously rejected the proposal, stating that it still significantly undervalues the company and its future prospects.

Elementis chair Andrew Duff commented: “Elementis has refocused its business and built strong market positions in three high-margin specialist sectors with strong underlying growth. We have a clear strategy to capture this growth and profitability and we are confident that this will deliver significant value for our shareholders. It is the quality of these businesses that has attracted Minerals Technologies.”

In its assessment of Minerals’ offer, the Elementis board said the timing of the proposal was “highly opportunistic” and comes at a low point due to the impact of Covid-19 and the industrial cycle. It also fails to reflect expected earnings growth based on investments made.

The London-headquartered company added that trading in the fourth quarter of 2020 continues to be resilient and in line with expectations, noting that while demand is still impacted by the Covid-19 pandemic, sales in October and November have shown sequential progress versus the third quarter.

It noted that the closure last month of its plant in Charleston, West Virginia, USA, will deliver $10 million of annual supply chain savings in 2021. Production at Charleston has been consolidated at its facility in St. Louis, Missouri.

Author: Elaine Burridge, Freelance Journalist

Minerals Technologies submitted a third proposal on Dec. 4 to take over...
Minerals Technologies submitted a third proposal on Dec. 4 to take over Elementis. The US specialty minerals firm raised its cash offer to 130 pence per share, but the Elementis board has unanimously rejected the proposal, stating it significantly undervalues the company. (c) Jon Tyson

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.